收藏切换
Ligustroflavone mediates the resistance of non-small cell lung cancer to osimertinib by arresting G1/S phase
收藏切换
PDF
Tian LI1, Ting WANG2, Bao-juan XING2, Zi-heng HE2, Jiao CHEN2, Xue-ting CAI2, He CUI1, *, Peng CAO1, 2, *
Acta Pharmaceutica Sinica | 2023, 58(11) : 3349 - 3353
Less
收藏切换
Acta Pharmaceutica Sinica | 2023, 58(11): 3349-3353
Original Articles
Ligustroflavone mediates the resistance of non-small cell lung cancer to osimertinib by arresting G1/S phase
Full
Tian LI1, Ting WANG2, Bao-juan XING2, Zi-heng HE2, Jiao CHEN2, Xue-ting CAI2, He CUI1, *, Peng CAO1, 2, *
Affiliations
  • 1. School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
  • 2. Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China
Published: 2023-11-12 doi: 10.16438/j.0513-4870.2023-0382
Outline
收藏切换

Natural products are an important source for the development of antitumor lead compounds, but the pharmacological effects and regulatory mechanisms of natural products in osimertinib resistance in non-small cell lung cancer (NSCLC) are not well understood. The natural product ligustroflavone was used as the research object to analyze its efficacy in osimertinib-resistant NSCLC cells by cell proliferation assay and cell cycle detection. The potential targets of ligustroflavone in osimertinib-resistant NSCLC cells were screened by public databases and bioinformatics, molecular docking and microscale thermophoresis were used to identify the interaction between privet and target molecules. Western blot was used to detect the effect of privet on the target molecules and their downstream pathways. Ligustroflavone reduced the proliferation of osimertinib-resistant NSCLC cells, and could arrest the cell cycle. Cyclin-dependent kinase 6 (CDK6) was the potential target of ligustroflavone in osimertinib-resistant NSCLC cells. Ligustroflavone inhibited the activation of CDK6-Rb axis. Together, ligustroflavone could regulate osimertinib resistance in NSCLC cells by binding cell cyclin-related molecules. This study provides a theoretical basis for the targeted drug resistance of NSCLC with natural products, and also provides a new idea for the development of clinical drug combination.

non-small cell lung cancer  /  drug resistance  /  osimertinib  /  ligustroflavone  /  cyclin-dependent kinase 6
Tian LI, Ting WANG, Bao-juan XING, Zi-heng HE, Jiao CHEN, Xue-ting CAI, He CUI, Peng CAO. Ligustroflavone mediates the resistance of non-small cell lung cancer to osimertinib by arresting G1/S phase[J]. Acta Pharmaceutica Sinica, 2023 , 58 (11) : 3349 -3353 . DOI: 10.16438/j.0513-4870.2023-0382
Year 2023 volume 58 Issue 11
PDF
236
131
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2023-0382
  • Receive Date:2023-02-20
  • Online Date:2025-11-21
  • Published:2023-11-12
Article Data
Affiliations
History
  • Received:2023-02-20
  • Revised:2023-07-05
Funding
Affiliations
    1. School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
    2. Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2023-0382
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT